Showing results (1911-1920 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Fusion of the CH1 domain of IgG1 to epidermal growth factor (EGF) prolongs its retention in the blood but does not increase tumor uptakeJudy Wang, Raymond M Reilly, Paul Chen, et al.Cancer Biotherapy & Radiopharmaceuticals|January 16, 2002
Cleavable linkers to enhance selectivity of antibody-targeted therapy of cancerD L Kukis, I Novak-Hofer, S J DeNardoCancer Biotherapy & Radiopharmaceuticals|January 16, 2002
Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapyD G DeNardo, C Y Xiong, X B Shi, et al.Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Mitogens for curative therapy of HIV-1 infections; an updateBruce M WimerCancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma modelR P Gude, M G Jadhav, S G A Rao, et al.Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
A non-invasive approach for monitoring breast tumor cells during therapeutic interventionTandra R Chaudhuri, Zhihong Cao, Cristina Rodríguez-Burford, et al.Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Tumor regression of B16F10 melanoma in vivo by prevention of neovascularization: study on theophyllineLata G Menon, A D Ingle, R P GudeCancer Biotherapy & Radiopharmaceuticals|June 13, 2000
[111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinomaM Edgren, J E Westlin, K M Kälkner, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads?M G StabinCancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Pretargeting with the affinity enhancement system for radioimmunotherapyJ Barbet, F Kraeber-Bodéré, J P Vuillez, et al.Pageof 224